Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ · Healthcare
Corbus Pharmaceuticals Holdings, Inc. Total Liabilities 2015–2022
Corbus Pharmaceuticals Holdings, Inc. annual total liabilities history from 2015 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Corbus Pharmaceuticals Holdings, Inc. total liabilities as of December 31, 2022: 33.3M, a 13.72% decrease year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2022 were 33.3M, a 13.72% decrease from 2021.
- Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2021 were 38.6M, a 32.27% decrease from 2020.
- Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2020 were 57.0M, a 32.65% increase from 2019.
- Corbus Pharmaceuticals Holdings, Inc. total liabilities for 2019 were 43.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Corbus Pharmaceuticals Holdings, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $33 |
| 2021 | $39 |
| 2020 | $57 |
| 2019 | $43 |
| 2018 | $19 |
| 2017 | $9 |
| 2016 | $9 |
| 2015 | $4 |
Corbus Pharmaceuticals Holdings, Inc. Total Liabilities — FAQ
Corbus Pharmaceuticals Holdings, Inc. (CRBP) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBP's total liabilities history?
The chart and table above show Corbus Pharmaceuticals Holdings, Inc.'s total liabilities by year and by quarter, including the growth rate.